Phase 1b Trial of Dinaciclib With Pembrolizumab for Advanced Breast Cancer

Clinical trial NCT01676753 · COMPLETED

Trial details

NCT number: NCT01676753
Sponsor: Jo Chien
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced or Metastatic Breast Cancer Triple Negative Breast Cancer

Start date: 2016-12-28
Primary completion: 2020-06-30
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.